Yesterday during its annual news conference, the National Foundation for Infectious Diseases (NFID) said less than 1 in 5 ...

Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...

More than 18,000 people died after developing flu conditions over two winters - despite last year being a relatively mild ...

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...

With respiratory viruses ramping up as we look to cooler days, vaccination season has arrived again. The newest vaccine to protect against Covid-19 has hit pharmacies, and Allegheny County residents ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

The RSV vaccine programme was launched in Scotland in August, followed by rollouts in England, Wales, and Northern Ireland in ...

Fall brings cooler days and more time indoors. This makes it easier for viruses like influenza, COVID-19 and respiratory ...

Leaders from the Pennsylvania Departments of Health and Insurance this week encouraged all Pennsylvanians to stay up to date on their annual vaccinations to protect against flu, COVID-19, and ...

Forecasts suggest respiratory infections will be similar to last year's season. Vaccination rates will be a factor in the ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...